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Abstract
Objectives; The objective of this paper was to review the published evidence concerning the efficacy and potential 
for adverse reactions of modern dentifrices toothpastes. Data sources; Publications cited on MEDLINE since 
1990.  Some further pre-1990 publications are also referenced. Data selection; Studies concerning the efficacy of 
dentifrices and their components and any related putative adverse incidents. Data extraction; Papers were scru-
tinised for scientific and trial data. Data synthesis; Data concerning the efficacy of dentifrice components were 
summarised. Conclusions; The efficacy of fluoride salts in dentifrices in reducing dental caries is well established. 
Toothpastes, containing  triclosan, are effective in improving plaque control, gingivitis and periodontal health. 
Other toothpaste formulations are effective in reducing the formation of calculus, extrinsic tooth stain, dentine 
sensitivity and oral malodour. The consumer now has available a range of toothpastes which deliver oral health 
benefits. Adverse reactions to toothpastes are rare but should be considered in unexplained skin or respiratory al-
lergies and gingival or lip lesions.
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Introduction
Toothpastes are used almost universally in the devel-
oped world but, in some groups and cultures, people 
still practice traditional toothbrushing without denti-
frice with, for example, a miswak or salt. Dentifrices 
(toothpastes) have been used since antiquity but re-
cently, formulations which deliver active compounds 
aimed at preventing and/or treating oral diseases have 
been developed.  The history of toothpastes is reviewed 
elsewhere.(1)
Toothpastes; their regulation
A toothpaste may be classed as either a cosmetic or a 
medicine depending on the claims that are made and the 
level of certain constituents. 
The primary function of a toothpaste is to clean the teeth 
which is considered to be a cosmetic benefit. The use 
of words such as ‘protects’, ‘cleans’, ‘freshens breath’, 
‘fights bacteria which may cause gum problems’, ‘whit-
ens’ or ‘fights tartar’ are considered to be cosmetic 
claims. Toothpastes that contain up to 1500 ppm F can 
make claims such as, ‘cavity protection’, ‘helps prevent 
tooth decay’ and ‘fights tooth decay’ all of which are 
cosmetic claims. Cosmetic products can be marketed 
without clearance from any regulatory body but the 
manufacturer has an obligation to ensure that such prod-
ucts are safe and do not cause damage to health under 
normal conditions of use. The EEC Cosmetics Directive 
now obliges the manufacturer to include full ingredient 
listing in descending order or level in the product.  A 
full dossier on the product containing information on 
the raw materials, manufacturing, safety and proof of 
claims must be available at a specific address for in-
spection by a competent authority. 
A medicine is considered to be any substance used 
wholly or mainly for the purpose of treating or prevent-
ing disease. Claims such as ‘reduces hypersensitivity, 
‘reduces gingivitis’, ‘reduces gingival bleeding’ or ‘con-
trols periodontitis’, “prevents/treats dental caries” are me-
dicinal claims and must be approved by the Medicines 
and Healthcare Products Regulatory Agency (MHRA), 
formerly known as the Medicines Control Agency, who 
require evidence to support the effectiveness and safety 
of such products. This takes the form of an application 
for marketing authorisation to sell the product. 
There are three types of Product Licence:
• General Sales Licence (GSL), 
• Pharmacy (P) 
• Prescription only (POM).
A fluoride toothpaste containing up to1500 ppm F may 
be classed as either a cosmetic or medicine depending 
on the claims made for the product. Toothpastes con-
taining more than 1500 ppm F are classed automatically 
as prescription only medicines. 
Toothpaste constituents
Although toothpastes must by law be labelled with ac-
tive and inactive ingredients, not all components are al-
ways clear from the labelling. Toothpastes usually con-
tain excipients and active principles.  Excipients and the 
reasons for their inclusion are shown in Table 1. Some 
toothpastes  contain ‘glycerin’, which may be manufac-
tured synthetically or derived from animal fat. The lat-
ter are contraindicated for use on religious or cultural 
grounds. 
The first active principle added to  toothpaste was fluo-
ride - introduced in the USA in 1955 as an anti-caries 
agent (in the UK in the mid-1960s). Many  toothpastes 
now  deliver multiple benefits in addition to caries con-
trol. Such toothpastes need to be carefully formulated 
to ensure that active ingredients are not inactivated. 
For example, calcium carbonate binds sodium fluoride 
to render it fairly ineffective as an anti-caries agent; 
sodium monofluorophosphate on the other hand is not 
inhibited. 
Anticaries agents in toothpastes
-Fluoride (F)
Systematic reviews (2,3) have concluded that fluoride 
toothpastes are effective in reducing caries. Fluoride 
toothpastes reduce caries in the deciduous dentition by 
37% and  by 24% in the permanent dentition of children 
and adolescents (3). A meta-analysis also concluded 
that fluoride is effective in preventing caries in adults 
of all ages (4). The effectiveness of fluoride toothpastes 
are concentration dependent (3,5-7). Brushing with a 
fluoride toothpaste should be recommended twice daily, 
whilst rinsing with large volumes of water should be 
discouraged (8).
Various forms of fluoride, such as amine fluoride, stan-
nous fluoride, sodium fluoride and sodium monofluoro-
phosphate, have been used in toothpaste formulations. 
The relative effectiveness of these different fluoride salts 
has been the topic of much debate (9,10) but a systematic 
review concluded that they were equally effective (3).
Dentifrices containing fluorides in concentrations 
>1500ppm are classed as prescription only medicines 
(POM) and should be used only above the age of 10 
years and for the management of high caries risk indi-
viduals such as those with xerostomia or root surface 
caries.
-Non-fluoride anti-caries components
Non-fluoride anti-caries agents within toothpaste for-
mulations include agents containing calcium, phospho-
rus (phosphates; trimetaphosphates, pyrophosphates, 
glycerophosphates), metals (zinc, tin, aluminium, iron, 
manganese, molybdenum) and various antimicrobials.
(11). Although many agents have been identified in vari-
ous models few have been taken forward to clinical tri-
als in humans. 
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Calcium carbonate (chalk) is a common dentifrice abra-
sive and has dental plaque pH-raising properties(12) and 
may also raise plaque calcium levels, and help in remi-
neralisation (13).1
Table 1  Toothpaste excipients 
Abrasives Surfactants Humectants 
Alumina
Aluminium trihydrate 
Bentonite
Calcium carbonate 
Calcium pyrophosphate 
Dicalcium phosphate 
Kaolin
Methacrylate 
Perlite (a natural volcanic glass) 
Polyethylene 
Pumice
Silica 
Sodium bicarbonate 
Sodium metaphosphate 
Amine fluorides 
Dioctyl sodium sulfosuccinate 
Sodium lauryl sulfate (SLS) 
Sodium N lauryl sarcosinate 
Sodium stearyl fumarate 
Sodium stearyl lactate 
Sodium lauryl sulfoacetate 
Glycerol 
PEG 8 (polyoxyethylene glycol esters) 
Pentatol
PPG (polypropylene glycol ethers) 
Sorbitol
Water
Xylitol 
Gelling or binding agents Flavours Preservatives 
Carbopols
Carboxymethyl cellulose 
Carrageenan 
Hydroxyethyl cellulose 
Plant extracts (alginate, guar gum, 
gum arabic) 
Silica thickeners  
Sodium alginate 
Sodium aluminum silicates Viscarine 
Xanthan gum 
Aniseed
Clove oil 
Eucalyptus 
Fennel 
Menthol
Peppermint 
Spearmint 
Vanilla 
Wintergreen 
Alcohols
Benzoic acid 
Ethyl parabens 
Formaldehyde 
Methylparabens 
Phenolics (methyl, ethy, propyl ) 
Polyaminopropyl biguanide 
Colours Film agents Sweeteners 
Chlorophyll 
Titanium dioxide 
Cyclomethicone  
Dimethicone
Polydimethylsiloxane 
Siliglycol 
Acesulfame
Aspartame 
Saccharine
Sorbitol
Table 1. Toothpaste excipients.
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Antiplaque agents in toothpastes.
Most antiplaque agents in oral use are antiseptics or an-
timicrobials used in an effort to prevent attachment of 
biofilms, to influence bacterial proliferation, or to remove 
established dental plaque and/or alter its pathogenicity. 
Most successful antiplaque agents have prolonged reten-
tion on oral surfaces by adsorption followed by slow de-
sorption (substantivity). They should  have a broad anti-
bacterial spectrum, with low toxicity, compatibility with 
other toothpaste components and be of low toxicity.
-Triclosan 
Triclosan ((2,4,4’ trichlor-2’-hydroxydiphenyl ether) is a 
non-ionic chlorinated bisphenol widely used in personal 
products such as deodorants and soaps and appears to 
be safe, effective and well tolerated.  It is compatible 
with toothpaste components such as fluoride and sur-
factants and, by virtue of its inhibition of cyclo-oxygen-
ase/lipoxygenase pathways, is also anti-inflammatory. 
However, triclosan per se has only moderate substantiv-
ity and is not retained sufficiently long to have a sig-
nificant antibacterial effect, However, when combined 
with a co-polymer, polyvinylmethyl ether maleic acid 
(PVM/MA or Gantrez) its oral retention is significantly 
increased (14).  
Triclosan functions by inhibiting the enoyl-reductase 
enzymes of type II fatty acid synthases in susceptible 
bacteria, damaging the bacterial cytoplasmic mem-
brane, leading to leakage. It has a broad spectrum of an-
tibacterial activity and a significant anti-plaque effect, 
without staining the teeth.
Systematic reviews of six-month clinical studies have 
concluded that formulations containing triclosan and 
copolymer significantly improve plaque control and 
periodontal health (15-17). Toothpastes containing tri-
closan and zinc citrate are also effective in improving 
plaque control and gingival health (18-21).
-Chlorhexidine
Early studies indicated anti-plaque activity of chlorhex-
idine (CHX) toothpastes (22), but it is inactivated by 
other constituents in conventional formulations.
Other anti-plaque ingredients
A systematic review concluded that toothpastes con-
taining stannous fluoride improve plaque control and 
gingivitis (23).
Herbal toothpastes have rarely been shown to have sig-
nificantly greater anti-plaque activity than conventional 
pastes (24).
A zinc citrate/bromochlorophene/triglyceride formula-
tion has been reported to inhibit both plaque and gingi-
val inflammation (25).
Whitening toothpastes
The evidence to date suggests that that the primary 
stain removal ingredient in toothpaste is the abrasive 
but some toothpastes do contain additional chemical 
agents that augment the abrasive cleaning. A number 
of the whitening ingredients that have been assessed 
include enzymes, peroxide, surfactants, citrate, pyro-
phosphates and hexametaphosphate. Whitening denti-
frices may contain
• Enzymes ( such as natural fruit enzymes of the Bro-
maine complex in Janina Diamond® and Opale® tooth-
pastes, and citroxain in Rembrandt toothpaste®)
• Peroxide (for instance, in Colgate Simply White Tooth-
paste®)
• Sodium hexametaphosphate (polypyrophosphate) or
• Sodium tripolyphosphate.
A  number of the whitening toothpaste ingredients are 
effective at stain removal in laboratory studies (26) but 
evaluating their clinical benefit is problematic. A tooth-
paste containing 0.5% calcium peroxide significantly 
reduced tooth stain after 6 weeks of product use (27). 
A toothpaste packaged as a dual chambered container 
where one stream contained 1% hydrogen peroxide the 
other phosphate salts, manganese gluconate and silica 
removed significant amounts of extrinsic tooth stain 
after 6 weeks (28). A clinical study demonstrated that 
dentifrices containing 0.234% sodium fluoride with 
copolymer, tetrasodium pyrophosphate, and sodium 
tripolyphosphate in a silica base, or 0.243% sodium 
fluoride with copolymer, tetrasodium pyrophosphate, 
and sodium tripolyphosphate in a silica base were more 
effective in preventing natural extrinsic staining com-
pared with a control dentifrice (29. A double-blind clini-
cal study indicated that Colgate Tartar Control® with 
Baking Soda & Peroxide Fluoride Toothpaste is signifi-
cantly better at control of extrinsic tooth stain than is 
Crest Regular Fluoride®, a sodium fluoride/silica den-
tifrice (30). 
Anti-calculus toothpastes (tartar control tooth-
pastes)
Supragingival calculus is mineralised plaque and one 
approach to its control is the inhibition of mineralisa-
tion by crystal growth inhibitors. Such  inhibitors in-
clude chemicals such as pyrophosphates, phosphonates 
zinc salts and a copolymer of methyl vinyl ether and 
maleic anhydride (31). A clinical trial of a toothpaste 
containing zinc citrate trihydrate and triclosan 
in a silica-base containing 1450 ppm F significantly re-
duced calculus (32). A number of studies have assessed 
dentifrices containing 3.3% soluble pyrophosphate and 
reported significant reductions in calculus (33-37). The 
addition of a copolymer (polyvinyl ether and maleic 
acid) to formulations containing pyrophosphate has 
been found to improve their effectiveness in reducing 
calculus (38,39). Clinical studies have established that 
a toothpaste containing triclosan/copolymer is effective 
in reducing calculus (40,41).
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Anti-malodour toothpastes
A toothpaste containing triclosan/co-polymer/sodium 
fluoride (Colgate®, Total®,  Advanced Fresh) is effec-
tive in reducing oral bacteria and malodour as well as 
reducing the volatile sulphur compounds implicated in 
malodour (42,43).
Desensitising toothpastes
Exposed root surfaces due to gingival recession are a 
major predisposing factor to dentinal root sensitivity 
which is often exacerbated after periodontal treatment. 
Two groups of products are used to treat sensitivity; those 
that interfere with the transmission of neural impulses 
and those that block and occlude the dentinal tubules.
Potassium nitrate (5%), potassium chloride (3.75%) and 
potassium citrate (5.5%) are used interchangeably in 
many countries since each of these salts provides 2% 
potassium ion which acts to block neural transmission.  
In clinical trials, potassium based toothpastes have been 
shown to take at least two weeks of twice daily use to 
provide measurable reductions in sensitivity. Clinical 
data indicate that all three forms of potassium are effec-
tive in reducing sensitivity when compared to a regular 
fluoride toothpaste (44-48). However, a systematic re-
view questioned the effectiveness of potassium contain-
ing formulations (49).  
Strontium chloride and stannous fluoride both involve 
the principle of occluding tubules. These products pro-
vide significant reductions in hypersensitivity after four 
weeks of twice daily use (50-52). 
Recently a novel formulation has been launched whose 
mode of action is to occlude dentinal tubules. The denti-
frice contains 8% arginine, calcium carbonate and 1450 
ppm fluoride as sodium monofluorophosphate. Several 
clinical studies have demonstrated the effectiveness of 
this product (53,54).  Using a range of techniques such 
as confocal laser scanning electron microscopy and 
atomic force microscopy the formulation was shown to 
occlude the dentinal tubules (55). 
Interactions of dentifrices with other oral health 
care products
Toothpastes may interact with, for example, cetylpyrid-
inium chloride mouthrinses to reduce the plaque-inhib-
itory effects (56).
It may be sensible therefore, to leave a period of a cou-
ple of minutes between use of mouthwashes and tooth-
pastes.
Possible adverse effects of dentifrices
Toothpaste ingredients may be ingested, particularly 
by children or people with learning disability, and may 
contribute to damage to hard tissues (abrasion, staining) 
and occasionally  soft-tissues. 
-Fluoride
Fluoride may be ingested from toothpaste, particularly 
by young  children   and fluorosis can result (57-59). The 
risk of fluorosis is related to the dose of fluoride ingest-
ed ie the fluoride concentration x amount. The amount 
of toothpaste poses a greater risk than the fluoride con-
centration and  parents should be advised to supervise 
toothbrushing, place only a small amount of toothpaste 
on the toothbrush and encourage the child to spit out ex-
cess. A recent publication by the Department of Health 
and the British Association for the Study of Community 
Dentistry, entitled “ Delivering Better Oral Health: An 
evidence based toolkit for prevention” recommends a 
smear of toothpaste containing at least 1000 .ppm fluo-
ride for children aged up to 3 years and for those aged 
3 to 6 years a pea sized amount of toothpaste contain-
ing 1350-1500 ppm fluoride (60). Toothpaste alone was 
responsible for an average of 81.5% of the daily fluoride 
intake in  pre-school Brazilian children (61). 
-Sodium lauryl sulfate
Sodium lauryl sulphate (SLS) is a detergent commonly 
used in toothpastes and may occasionally cause mucos-
al desquamation or ulceration (62-64).
-Triclosan
In 2005, a “toothpaste cancer alert” appeared in some 
newspapers after a report that triclosan can react with 
water to produce chloroform (65) which, if inhaled in 
large enough quantities, can cause depression, liver 
problems and, in some cases, cancer. However, other 
studies suggest that triclosan may have chemotherapeu-
tic potential against cancer (66).
-Soft tissue reactions
Soft tissue reactions may arise, most often to essential 
oils, flavourings, cinnamonaldehyde, benzoates, or car-
vone, and manifest as direct irritants or allergic reac-
tions in the mouth, lips as contact cheilitis (67). Rarely 
allergic rhinitis (68) or asthma (69) may occur.
Essential oils, such as peppermint, anethole, cinnamon, 
cloves and spearmint and antimicrobial agents can 
cause cheilitis or circumoral dermatitis (70). Carvone 
is a common constituent of essential oils and may be 
implicated.
Some toothpaste constituents have been implicated in 
other reactions. Tartar-control pyrophosphate dentifric-
es occasionally cause  erythema, scaling and fissuring 
of the perioral area, sometimes with cheilitis, gingivitis 
(71) and circumoral dermatitis (72) and other reactions. 
Herbal toothpastes occasionally produce similar reac-
tions (73).
Conclusion
The clinical team has a responsibility to keep up-to-
date with the ever-increasing development and market-
ing of dentifrices. In the past the profession has had to 
rely on data obtained from clinical trials some of which 
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were of poor quality. The regulatory bodies have done 
much to improve the quality of trials and review and 
approve claims made by the manufacturers. The Co-
chrane Oral Health Group has been at the forefront in 
publishing systematic reviews of randomised controlled 
clinical trials involving toothpastes. Clinicians can feel 
confident that the advice derived from such reviews is 
sound and based on a rigorous process of appraisal. Un-
til recently toothpastes, notably those containing fluo-
ride, delivered the single benefit of caries prevention. 
Today the composition of toothpastes is complex often 
delivering several oral health benefits. Much of the im-
provement in the oral health of individuals, communi-
ties and populations can be attributed to the widespread 
availability  and use of safe and effective toothpastes.
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